Search

everythinglearnresearchcommunity

for

Search:↓

Standardizing PRP therapy practices and regulations in Europe is crucial for safe and effective treatment.

Hair graying is caused by damage and cell depletion but might be temporarily reversible with drugs and hormones.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Social media can help compare the effectiveness and safety of new arthritis medications.

The DLQI is a key tool for measuring quality of life in dermatology.

Some drugs may help treat both COVID-19 and radiation injury.

People with skin diseases often face bullying, and global efforts are needed to stop it.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Nonhuman primates are valuable in research but their natural health variations can complicate study results.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Dupilumab treatment reduces Th2-related markers and helps hair growth in alopecia areata, showing Th2's role in the condition.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

High doses of albendazole can be deadly for alpacas.

Blocking the KATP channel may help treat migraines.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

Vitiligo is underreported in medical claims and is linked to certain skin types and autoimmune diseases.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

Topical clascoterone may help treat hidradenitis suppurativa.

Alopecia areata greatly affects people's life quality, mental health, and work life.

Adding a second method to PROTACs could improve cancer treatment.

More people are using Google to search for skin problems like itch, hair loss, and rashes.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

The journal Anais Brasileiros de Dermatologia has grown significantly in influence and visibility over the past decade.

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

Alopecia Areata causes significant structural and compositional changes in hair.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.